DRIEHAUS CAPITAL MANAGEMENT LLC
Institutional investor · Portfolio as of Q4 2022
Top Holdings346 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/ | 3.4M | $253.8M | 3.8% | $54.00 | +31.64% | 16 qtrssince 2019-Q1 | Decreased 0 |
XENON PHARMACEUTICALS INC | 4.7M | $184.6M | 2.8% | $26.44 | +49.12% | 12 qtrssince 2020-Q1 | Increased 54 |
CALIX INC | 1.8M | $122M | 1.8% | $47.84 | +43.03% | 10 qtrssince 2020-Q3 | Increased 50 |
ICICI BANK LTD-SPON ADR | 4.8M | $105.7M | 1.6% | $15.02 | +42.18% | 16 qtrssince 2019-Q1 | Increased 54 |
CRINETICS PHARMACEUTICALS IN | 5.6M | $102.9M | 1.5% | $20.84 | -12.17% | 11 qtrssince 2020-Q2 | Decreased 0 |
WILLSCOT HOLDINGS CORP | 2.2M | $99M | 1.5% | $35.31 | +26.48% | 6 qtrssince 2021-Q3 | Decreased 0 |
AXCELIS TECHNOLOGIES INC | 1.1M | $90M | 1.3% | $65.26 | +21.61% | 8 qtrssince 2021-Q1 | Increased 69 |
KINSALE CAP GROUP INC | 319,221 | $83.5M | 1.2% | $231.05 | +12.68% | 5 qtrssince 2021-Q4 | Increased 49 |
Impinj, Inc. | 718,973 | $78.5M | 1.2% | $72.04 | +51.55% | 8 qtrssince 2021-Q1 | Decreased 0 |
HALOZYME THERAPEUTICS INC | 1.3M | $76.4M | 1.1% | $39.25 | +44.99% | 12 qtrssince 2020-Q1 | Decreased 0 |
INSPIRE MED SYS INC | 297,470 | $74.9M | 1.1% | $171.27 | +47.07% | 16 qtrssince 2019-Q1 | Increased 52 |
e.l.f. Beauty, Inc. | 1.3M | $73.1M | 1.1% | $34.39 | +60.82% | 4 qtrssince 2022-Q1 | Increased 56 |
TransMedics Group, Inc. | 1.1M | $68M | 1.0% | $38.17 | +61.71% | 3 qtrssince 2022-Q2 | Increased 52 |
ATI INC | 2.1M | $61.9M | 0.9% | $26.53 | +12.57% | 4 qtrssince 2022-Q1 | Decreased 0 |
VISTEON CORP | 472,305 | $61.8M | 0.9% | $112.15 | +16.07% | 4 qtrssince 2022-Q1 | Increased 49 |
DICE THERAPEUTICS INC | 2M | $61M | 0.9% | — | — | 6 qtrssince 2021-Q3 | Decreased 0 |
TRIP.COM GROUP LTD-ADR | 1.7M | $57.3M | 0.9% | $27.32 | +25.31% | 3 qtrssince 2022-Q2 | Decreased 0 |
SHOALS TECHNOLOGIES GROUP IN | 2.3M | $56.6M | 0.8% | $23.27 | +6.01% | 2 qtrssince 2022-Q3 | Increased 67 |
HDFC BANK LTD-ADR | 818,548 | $56M | 0.8% | $28.04 | +16.64% | 16 qtrssince 2019-Q1 | Decreased 0 |
CELSIUS HOLDINGS INC | 523,981 | $54.5M | 0.8% | $13.82 | +151.00% | 11 qtrssince 2020-Q2 | Decreased 0 |
DRIEHAUS CAPITAL MANAGEMENT LLC manages $6.7B across 346 positions as of Q4 2022. Top holdings: TSM (3.8%), XENE (2.8%), CALX (1.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 92 new positions, 89 exits, 114 increased. Top move: ACLS (INCREASED, conviction 69). Portfolio: $6.7B across 346 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer